{
 "PrintNo":"S1523","Session":2023,"Chamber":"SENATE","BillType":"Senate","Published":"2023-01-12T12:36:57.258372Z",
 "Status":"IN_SENATE_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_SENATE_COMM","Date":"2024-01-03","Committee":"Health"}],
 "Actions":[
  {"Text":"REFERRED TO HEALTH","Date":"2023-01-12","Chamber":"SENATE"},
  {"Text":"REFERRED TO HEALTH","Date":"2024-01-03","Chamber":"SENATE"}
 ],
 "Sponsors":[
  {"ID":914,"Name":"Roxanne J. Persaud","Short":"PERSAUD"},
  {"ID":438,"Name":"Brad Hoylman-Sigal","Short":"HOYLMAN-SIGAL"}
 ],
 "Title":"Requires clinical trials that apply for state grant funding to make certain information about such clinical trials public",
 "Summary":"Requires any sponsor of a clinical trial in this state, including but not limited to, a pharmaceutical drug manufacturer, pharmaceutical drug wholesaler, academic medical center, voluntary group, federal agency or health care provider, that applies for a state grant to conduct such clinical trial, to conspicuously post certain information about such clinical trial on the department's website.",
 "LawSection":"Public Health Law","LawCode":"Add Art 2 Title 9 §§269-b - 269-d, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to requiring clinical trials that apply for state grant funding to make certain information about such clinical trials public",
 "SameAsPrintNo":"A8197-2023","PreviousVersions":["S8190-2021"]
}